Posticy
Boost your SEO with Backlinks that are worth it
SR Ranko
Turn scattered startup information into focused action.
SR Booster
Submit your startup to 120+ top directories.

ELAN BioPharmaceuticals - Geiss, Destin & Dunn

ELAN BioPharmaceuticals acquires Geiss, Destin & Dunn

Announced: August 17, 2016

Type:           Acquisition
Disposition: Subsidiary
Status:         Complete

Amount:       Undisclosed amount

Acquisition News

Add News

Date Title
There are no news.

ELAN BioPharmaceuticals Other Acquisitions

Add Acquisition

Date Acquired Amount
Sep 09, 2015
ScarAway
Undisclosed amount
Nov 06, 2014
Omega Pharma NV
$ 4,500,000,000
Aug 05, 2013
Elan Corporation
$ 8,600,000,000
Jun 17, 2013
Fera Pharmaceuticals
Undisclosed amount
Feb 11, 2013
Rosemont Pharmaceuticals
£ 183,000,000
View more acquisitions »